Literature DB >> 26590950

Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects.

Marianela Lorier1,2, Laura Magallanes1,2, Manuel Ibarra1,2, Natalia Guevara1,2, Marta Vázquez1,2, Pietro Fagiolino3,4.   

Abstract

BACKGROUND AND OBJECTIVES: Ketoprofen, a potent nonsteroidal anti-inflammatory drug, is clinically administered as a racemic mixture. One of the possible metabolism routes of ketoprofen is the inversion of the R- to S-enantiomer in the gastrointestinal tract. Ketoprofen, as a weak acid drug, might undergo recirculation through pancreatic/intestinal juices. The aim of the work was to investigate if a plasma-gastrointestinal tract recirculation of ketoprofen could explain its R-to-S chiral inversion after the oral administration of two modified-release formulations: a gastro-resistant delayed-release tablet (Reference) and an extended-release-plus-immediate-release bilayer tablet (Test).
METHODS: Sixteen healthy Caucasian volunteers (eight women and eight men) participated in a ketoprofen bioequivalence study. Both formulations were administered with and without food. In both cases, standard meals were given throughout the experiment. R- and S-enantiomers were measured separately using a validated HPLC-UV chiral method. Mean concentration-time profiles of ketoprofen enantiomers in plasma were obtained for men and women. Area under the plasma concentration-time curve, maximum ketoprofen plasma concentration, and time-to-peak were also computed for both isomers, both modes of administration, and both sexes. S/R concentration ratio was assessed as an indicator of enantiomer chiral inversion rate.
RESULTS: Differences in the pharmacokinetics of S- and R-ketoprofen enantiomers were found after the Test administration. S-Ketoprofen presented a lower plasma exposure compared to R-enantiomer. However, the S/R concentration ratio increased 1 h (in men) and 2 h (in women) after meal intakes. This was related to pancreatic and/or intestinal and/or biliary secretions of the drug, followed by reabsorption and conversion of the R- to the S-isomer. The lower intestinal pH reported for men would lead to a higher oral bioavailability of the Test formulation and a higher reabsorption of both ketoprofen isomers in this sex. Hence, a higher rise of the S/R concentration ratio could be observed in men. No significant differences between isomers exposure were detected in both sexes after the Reference administration. Different lag times were observed after fed and fasting administration of this formulation; however, drug absorption coincided with food ingestion. Then, drug recirculation affected the S/R ratio from the beginning of drug exposure, minimizing the difference between isomers disposition.
CONCLUSIONS: R-to-S conversion rate could be mainly associated with several passages of the drug through the intestinal mucosa. The concentration-time profiles of ketoprofen in plasma after the administration of both formulations evidenced R-to-S conversion of recirculating drug following meal intakes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26590950     DOI: 10.1007/s13318-015-0313-2

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  18 in total

1.  Non-ionic diffusion and the excretion of weak acids and bases.

Authors:  M D MILNE; B H SCRIBNER; M A CRAWFORD
Journal:  Am J Med       Date:  1958-05       Impact factor: 4.965

2.  Sex and Food Influence on Intestinal Absorption of Ketoprofen Gastroresistant Formulation.

Authors:  Laura Magallanes; Marianela Lorier; Manuel Ibarra; Natalia Guevara; Marta Vázquez; Pietro Fagiolino
Journal:  Clin Pharmacol Drug Dev       Date:  2015-08-10

3.  Stereoselective pharmacokinetics of ketoprofen in the rat. Influence of route of administration.

Authors:  R T Foster; F Jamali
Journal:  Drug Metab Dispos       Date:  1988 Jul-Aug       Impact factor: 3.922

4.  Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination.

Authors:  N G Grubb; D W Rudy; D C Brater; S D Hall
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

5.  Chiral separation of beta-adrenergic antagonists, profen non-steroidal anti-inflammatory drugs and chlorophenoxypropionic acid herbicides using teicoplanin as the chiral selector in capillary liquid chromatography.

Authors:  B Kafková; Z Bosáková; E Tesarová; P Coufal
Journal:  J Chromatogr A       Date:  2005-09-23       Impact factor: 4.759

Review 6.  Clinical pharmacokinetics of ketoprofen and its enantiomers.

Authors:  F Jamali; D R Brocks
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

7.  Stereoselective binding of mexiletine and ketoprofen enantiomers with human serum albumin domains.

Authors:  Da Shi; Yin-xiu Jin; Yi-hong Tang; Hai-hong Hu; Si-yun Xu; Lu-shan Yu; Hui-di Jiang; Su Zeng
Journal:  Acta Pharmacol Sin       Date:  2012-05       Impact factor: 6.150

8.  Pharmacokinetics of ketoprofen enantiomers after different doses of the racemate.

Authors:  G Geisslinger; S Menzel; K Wissel; K Brune
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

Review 9.  Antiepileptic drugs: Energy-consuming processes governing drug disposition.

Authors:  Pietro Fagiolino; Marta Vazquez; Silvana Alvariza; Cecilia Maldonado; Manuel Ibarra; Ivette Olano
Journal:  Front Biosci (Elite Ed)       Date:  2014-06-01

10.  STUDIES ON THE ELIMINATION OF DYES IN THE GASTRIC AND PANCREATIC SECRETIONS, AND INFERENCES THEREFROM CONCERNING THE MECHANISMS OF SECRETION OF ACID AND BASE.

Authors:  R C Ingraham; M B Visscher
Journal:  J Gen Physiol       Date:  1935-05-20       Impact factor: 4.086

View more
  6 in total

1.  Influence of Sex and Food on the Bioavailability and the R-to-S Conversion of Ketoprofen Stereoisomers in Humans.

Authors:  Pietro Fagiolino; Nikoletta Fotaki; Marta Vázquez
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

2.  Stereoselective Conversion of Ketoprofen in Men Versus Women from Two Different Oral Dosage Formulations: Observations and Introspection of the Pharmacokinetic Data.

Authors:  Ranjeet Prasad Dash; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

3.  Antinociception produced by nonsteroidal anti-inflammatory drugs in female vs male rats.

Authors:  Rebecca M Craft; Kelly A Hewitt; Stevie C Britch
Journal:  Behav Pharmacol       Date:  2021-04-01       Impact factor: 2.277

4.  Organism-specific differences in the binding of ketoprofen to serum albumin.

Authors:  Mateusz P Czub; Alan J Stewart; Ivan G Shabalin; Wladek Minor
Journal:  IUCrJ       Date:  2022-07-16       Impact factor: 5.588

Review 5.  Sex-Specific Pharmacotherapy for Migraine: A Narrative Review.

Authors:  Parisa Gazerani; Brian E Cairns
Journal:  Front Neurosci       Date:  2020-03-20       Impact factor: 4.677

Review 6.  Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs.

Authors:  Raymond E Lai; Christopher E Jay; Douglas H Sweet
Journal:  J Food Drug Anal       Date:  2018-03-24       Impact factor: 6.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.